6533b830fe1ef96bd1297204

RESEARCH PRODUCT

Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?

Enrico HefflerAikaterini DetorakiMarco ContoliAlberto PapiGiovanni PaolettiGiacomo MalipieroLuisa BrussinoClaudia CrimiDaniela MorroneMarianna PadovaniGiuseppe GuidaAlberto Giovanni GerliStefano CentanniGianenrico SennaPierluigi PaggiaroFrancesco BlasiGiorgio Walter Canonica Sani Working GroupM. BonaviaC. BuccaM. F. CaiaffaC. CalabreseG. CamiciottoliC. CarusoM. E. ConteA. G. CorsicoL. CosmiM. T. CostantinoN. CrimiS. D’alòM. D’amatoS. Del GiaccoA. FarsiE. FaveroB. M. P. FoschinoG. GuarnieriS. Lo CiceroC. LombardiL. MacchiaF. MazzaF. MenzellaM. MilaneseP. MontuschiM. MontagniE. NuceraR. ParenteG. PassalacquaV. PatellaG. PelaiaL. PiniF. PuggioniL. RicciardiF. L. M. RicciardoloL. RicheldiE. RidoloG. RollaP. SantusN. ScichiloneP. SolidoroG. SpadaroA. VianelloV. VivianoM. R. YacoubM. C. Zappa

subject

severe asthma2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Severe asthmaImmunologyComorbiditySettore MED/10 - Malattie Dell'Apparato RespiratorioCOVID-19 severe asthma COPDNOHumans; SARS-CoV-2; Asthma; COVID-19Internal medicineCorrespondencemedicineCOPDImmunology and AllergyHumansAsthmaCOVIDbusiness.industrySARS-CoV-2COVID-19asthmamedicine.diseaseItalybusiness
yearjournalcountryeditionlanguage
2021-03-01
10.1111/all.14593http://hdl.handle.net/10447/492737